Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Cheng

Showing results (481-490 of 557) with videos related to

Pageof 56
Sort By:
JHEP Reports : Innovation in Hepatology|December 24, 2025
Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitisShih-Chieh Chien, Chiung-Yu Chen, Hung-Wen Tsai, et al.
Viruses|November 11, 2022
Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative ResectionShih-Chieh Chien, Yih-Jyh Lin, Chun-Te Lee, et al.
The Kaohsiung Journal of Medical Sciences|January 10, 2023
Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysisPei-Min Hsieh, Pojen Hsiao, Yaw-Sen Chen, et al.
Nature Communications|December 19, 2018
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancerQingzhu Jia, Wei Wu, Yuqi Wang, et al.
Alimentary Pharmacology & Therapeutics|October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Gastroenterology and Hepatology|February 20, 2019
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infectionLai Wei, Hiromitsu Kumada, Ponni V Perumalswami, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 21, 2022
Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia ANoppaket Singkham, Baralee Punyawudho, Ming-Sun Yu, et al.
Journal of Gastroenterology and Hepatology|April 14, 2024
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registryRheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, et al.
Viruses|November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in TaiwanChun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Pageof 56

Showing results (481-490 of 557) with videos related to

Sort By:
Pageof 56
JHEP Reports : Innovation in Hepatology|December 24, 2025
Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitisShih-Chieh Chien, Chiung-Yu Chen, Hung-Wen Tsai, et al.
Viruses|November 11, 2022
Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative ResectionShih-Chieh Chien, Yih-Jyh Lin, Chun-Te Lee, et al.
The Kaohsiung Journal of Medical Sciences|January 10, 2023
Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysisPei-Min Hsieh, Pojen Hsiao, Yaw-Sen Chen, et al.
Nature Communications|December 19, 2018
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancerQingzhu Jia, Wei Wu, Yuqi Wang, et al.
Alimentary Pharmacology & Therapeutics|October 27, 2018
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Journal of Gastroenterology and Hepatology|February 20, 2019
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infectionLai Wei, Hiromitsu Kumada, Ponni V Perumalswami, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 19, 2018
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 21, 2022
Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia ANoppaket Singkham, Baralee Punyawudho, Ming-Sun Yu, et al.
Journal of Gastroenterology and Hepatology|April 14, 2024
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registryRheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, et al.
Viruses|November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in TaiwanChun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Pageof 56